menu search

60 Degrees Pharmaceuticals Awarded U.S. Patent Covering Tafenoquine for Treatment of COVID-19 and Other Lung Infections

60 Degrees Pharmaceuticals Awarded U.S. Patent Covering Tafenoquine for Treatment of COVID-19 and Other Lung Infections
Patent provides exclusive use through 2040 of tafenoquine for treatment of COVID-19 and other lung infections. Tafenoquine is the active molecule in 60P’s FDA-approved drug for malaria prevention, ARAKODA®. Data from a Phase II study completed last year suggest a positive therapeutic signal in mild-moderate COVID-19 disease using the ARAKODA regimen of tafenoquine. Later this […] The post 60 Degrees Pharmaceuticals Awarded U.S. Patent Covering Tafenoquine for Treatment of COVID-19 and Other Lung... Read More
Posted: Apr 26 2023, 11:34
Author Name: forextv
Views: 081975

Search within

Pages Search Results: